Central Nervous System (CNS) and Lupus: Learn from the Experts. Betty Diamond, M.D. Feinstein Institute for Medical Research
|
|
- Stephen Chandler
- 6 years ago
- Views:
Transcription
1 Central Nervous System (CNS) and Lupus: Learn from the Experts Betty Diamond, M.D. Feinstein Institute for Medical Research
2 Stages in SLE Pathogenesis Crow MK, Arth Res & Tx. 2009
3 ACR Criteria for the Classification of SLE Malar rash Discoid rash Photosensitivity Oral Ulcers Arthritis Serositis Renal disorder Neuropsychiatric disorder Hematologic disorder Immunologic disorder Antinuclear antibody
4 ACR Criteria for the Classification of NPSLE Central Nervous System Brain & Spinal Cord Cognitive dysfunction Headache Mood disorder Anxiety Psychosis Acute Confusion-Delirium Demyelinating syndrome Seizures Aseptic meningitis Movement disorder (chorea) Myelopathy Vascular disease* Peripheral Nervous System Cranial neuropathy Polyradiculopathy Plexopathy Autonomic disorder Mononeuropathy Polyneuropathy Myasthenia gravis
5 Neuropsychiatric SLE Over 80% of SLE patients experience some type of nervous system manifestation at some time during the disease course Seizures and psychosis are the only manifestations that are part of the diagnostic criteria for the diagnosis of SLE
6 Neuropsychiatric SLE: Risk Factors Antiphospholipid antibodies: thrombosis, thrombocytopenia, recurrent fetal loss, cognitive problems Anti-ribosomal P antibodies: psychosis Anti-glutamate receptor antibodies: cognitive problems, depression Secondary effects of renal disease, vascular disease infection and medication side effects
7 Prevalence of Neuro-Psychiatric SLE using ACR nomenclature Number of Patients Disease duration Tampere, Finland SanAntonio, US London,UK Caligari, Italy Albuquerque, US Halifax, Canada ±8 8 11±8 7±8 10±1 Total with NP-SLE 91% 80% 57% 95% 37% Hanly J. Lupus 2004
8 Prevalence of Neuropsychiatric SLE NPSLE manifestations occur as single or multiple events even during periods of no non-nervous system disease activity 40% of NPSLE manifestations develop before diagnosis of SLE 63% occur within first year of diagnosis
9 Most Common Manifestations of Neuropsychiatric SLE Central Nervous System Percent Cognitive dysfunction (n=249) 55-80% Headache (n=683) 24-54% Mood disorder (n=314) 14-57% Cerebrovascular Disease (n=490) 5-18% Seizures (n=509) 6-51% Anxiety (n=128) 24% Psychosis (n=323) 8% Peripheral Nervous System Polyneuropathy (n=46) 28%
10 Cognitive Dysfunction NPSLE Syndromes: Cognitive Attention Concentration Memory Word-finding Importance of corticosteroid use controversial Impairment not always progressive Waxing and waning symptoms not always associated with flare. Confounding influences of depression, medication, pain, fatigue, and now age as patient survival has increased.
11 Pathophysiology for the Most Common Neuropsychiatric Symptoms Vascular Pathology (n=141; 75%) Thrombosis, Infarct; micro (49%), macro (18%) Hemorrhagic Infarct; micro (28%), macro (17%) Inflammation Vasculitis (7%) Atherosclerosis (2-7 fold prevalence) Blood-Brain Barrier Breach and Direct Neurotoxicity Medications
12 Immunopathology B cells & Autoantibodies Anti-phospholipid Ab (APL)= vascular disease Anti-ribosomal-P Antibody CROSS REACTS with neuron surface protein 331 Anti-DNA antibody CROSS REACTS with N methyl D aspartate receptor (NMDAR) on neurons
13 Anti-brain Antibodies Cause Cognitive and Behavioral Problems in Laboratory Models lupus antibody no antibody lupus antibody lupus antibody The blood-brain barrier protects the brain from antibodies in the blood. Infection or stress can compromise the blood-brain barrier.
14 Lupus Ab Binds NMDAR and Causes Neuronal Death or Dysfunction in vivo Antibody Induced Neuron Death Enhancement of NMDAR Responses SLE Control
15 Anti-brain Antibodies from SLE Patients Cause Neuronal Death In Vitro Hu anti-pep serum cerebrospinal fluid brain tissue SLE CSF Non-SLE CSF +MK801 SLE CSF Hu control Non-SLE CSF CSF titers of antibody correlate with CNS symptoms
16 Anti-brain Antibodies in CSF of Patients with SLE CNS = central nervous system SLE PNS = peripheral nervous system SLE S = SLE patients undergoing surgery (no NPSLE) NA = non-autoimmune controls
17 Anti-brain Antibodies in CSF of Patients with SLE Yoshio et al. Arthritis & Rheumatism, 2006
18 Therapy for NPSLE There are no specific drugs for NPSLE manifestations. Drugs used are the same ones we use to treat other serious lupus manifestations Steroids Imuran Cytoxan Cellcept Others
19 Symptomatic Treatments Medications Drugs used to treat headache, seizures, stroke and other NPSLE manifestations work as well in SLE patients as in people without SLE Many SLE patients (up to 66%!) use alternative medicines Non-Pharmacologic Stress management Life-style changes Psychotherapy Cognitive rehabilitation
20 Summary Brain involvement in SLE is frequent and the sequelae may increase with disease severity and duration. Pathophysiology depends on cytokines, stress hormones, drugs and also on the specificity and concentration of antibrain antibodies and their ability to penetrate the bloodbrain barrier. CSF antibody titers may better reflect brain symptoms than serum antibody titers. Vascular compromise and subsequent brain injury results from APL Ab; rarely inflammatory vasculitis. Novel therapeutic opportunities include antibody blockade.
21 Project Collaborators Betty Diamond Czeslawa Kowal Eva Bertini Paola Mina- Osorio Meggan Mackay Cynthia Aranow Jorge Sanchez- Guerrero Matthew Scharff John Hardin Patricio Huerta Roseann Berlin Tom Faust Eric Chang Lori DeGiorgio Mark Edgar
Neuropsychiatric SLE (NPSLE) Dr. MTL NYO FCP(SA), Cert Rheum (Phys) Division of Rheumatology Department of Internal Medicine DGMAH / SMU
Neuropsychiatric SLE (NPSLE) Dr. MTL NYO FCP(SA), Cert Rheum (Phys) Division of Rheumatology Department of Internal Medicine DGMAH / SMU NPSLE represents a diagnostic and therapeutic challenge Wide range
More informationNeuropsychiatric Systemic Lupus Erythematosus (NPSLE) Case presentations and topic discussion The Rheumatology Unit UMMC experience
Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) Case presentations and topic discussion The Rheumatology Unit UMMC experience References Sanna G, Bertolaccini ML. Neuropsychiatric manifestations
More informationSituaciones estresantes en el lupus
Situaciones estresantes en el lupus Munther A Khamashta MD FRCP PhD Director: Lupus Research Unit Barcelona, Noviembre 2008 What is Lupus? Lupus is a neurological disease and sometimes affects other organs
More informationSystemic Lupus Erythematosus
Systemic Lupus Erythematosus Marc C. Hochberg, MD, MPH Professor of Medicine and Head, Division of Rheumatology University of Maryland School of Medicine CASE: HISTORY A 26-year-old woman is seen for migratory
More informationLUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS
LUPUS 101 LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS SLE SUBSETS SUBACUTE CUTANEOUS LUPUS DRUG INDUCED LUPUS NEONATAL LUPUS LATE ONSET LUPUS ANTI-PHOSPHOLIPID
More information9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) 1 Other Types of Lupus Discoid Lupus Erythematosus Lupus Pernio --- Sarcoidosis Lupus Vulgaris --- Tuberculosis of the face Manifestations of SLE Fever Rashes Arthritis
More informationCHAPTER 8. TREX1 gene variant in neuropsychiatric SLE
CHAPTER 8 TREX1 gene variant in neuropsychiatric SLE B. de Vries 1, G.M. Steup-Beekman 2, J. Haan 3,4, E.L.E.M. Bollen 3, J. Luyendijk 5, R.R. Frants 1, G.M. Terwindt 3, M.A. van Buchem 5, T.W.J. Huizinga
More informationManaging CNS involvement in systemic lupus erythematosus
Review Managing CNS involvement in systemic lupus erythematosus The occurrence of neuropsychiatric manifestations in systemic lupus erythematosus (NPSLE) represents a diagnostic and therapeutic challenge
More informationPediatric systemic lupus erythematosus
REVIEW Pediatric systemic lupus erythematosus Earl Silverman Professor of Pediatrics & Immunology, Division of Rheumatology, Hospital for Sick Children, Toronto, Ontario, Canada Tel.: +1 416 813 6249;
More informationHigh Impact Rheumatology
High Impact Rheumatology Systemic Lupus Erythematosus Bernard Rubin, DO MPH Case 1: History A 45-year-old woman presents with severe dyspnea and cough. She was in excellent health until 4 weeks ago when
More informationLiving with Lupus: An Insider s Perspective
Living with Lupus: An Insider s Perspective Pamela Thorpe, MD, FACP Lupus Foundation of America, Inc. Philadelphia Tri-State Chapter Volunteer May 2014 My Own Story Is it Lupus Yet? The What What is this?
More informationDefinition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he
LIVING WITH SYSTEMIC LUPUS ERYTHEMATOSUS Stacy Kennedy, M.D.,M.B.A. Rowan Diagnostic Clinic Salisbury, N.C. May 11, 2013 Agenda What is lupus Who is affected Causes of lupus Symptoms and organ involvement
More informationUNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS
UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS Stacy Kennedy, M.D.,M.B.A. October 20, 2012 Agenda What is lupus Who is affected Causes of lupus Symptoms and organ involvement Diagnosis Treatment Pregnancy
More informationCHAPTER 2. Early occurrence of neuropsychiatric manifestations in a large cohort of SLE patients
CHAPTER 2 Early occurrence of neuropsychiatric manifestations in a large cohort of SLE patients G.M. Steup-Beekman 1, B.M.A. Gahrmann 1, B.J. Emmer 2, S.C.A. Steens 2, E.L.E.M. Bollen 3, M.A. van Buchem
More informationONE of the following:
Medical Coverage Policy Belimumab (Benlysta) EFFECTIVE DATE: 01 01 2012 POLICY LAST UPDATED: 11 21 2017 OVERVIEW Belimumab (Benlysta ) is indicated for the treatment of adult patients with active, autoantibody-positive,
More informationSummary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z
Topic Page: Systemic Lupus Erythematosus Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z What Is It? Lupus is thought to develop when the immune system
More informationSystemic Lupus Erythematosus among Jordanians: A Single Rheumatology Unit Experience
Systemic Lupus Erythematosus among Jordanians: A Single Rheumatology Unit Experience Ala M. AlHeresh MD* ABSTRACT Objectives: To study the characteristics of Systemic Lupus Erythematosus in Jordan and
More informationContents 1 Immunology for the Non-immunologist 2 Neurology for the Non-neurologist 3 Neuroimmunology for the Non-neuroimmunologist
1 Immunology for the Non-immunologist... 1 1 The Beginnings of Immunology... 1 2 The Components of the Healthy Immune Response... 2 2.1 White Blood Cells... 4 2.2 Molecules... 8 References... 13 2 Neurology
More informationInsights into the DX of Pediatric SLE
Insights into the DX of Pediatric SLE Dr. John H. Yost Pediatric Rheumatology Children s Hospital at Dartmouth Assistant Professor of Medicine Geisel School of Medicine at Dartmouth john.h.yost@hitchcock.org
More informationBenlysta (belimumab) Prior Authorization Criteria Program Summary
Benlysta (belimumab) Prior Authorization Criteria Program Summary This prior authorization applies to Commercial, NetResults A series, NetResults F series and Health Insurance Marketplace formularies.
More informationPSYCHIATRIC MANIFESTATIONS IN PEDIATRIC SLE PATIENTS AT SIRIRAJ HOSPITAL BANGKOK, THAILAND
PSYCHIATRIC MANIFESTATIONS IN PEDIATRIC SLE PATIENTS AT SIRIRAJ HOSPITAL BANGKOK, THAILAND Sasitorn Chantaratin, Prae Wongtangman, Sudrat Sirisakpanit and Vitharon Boon-yasidhi Division of Child and Adolescent
More informationLupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?
Lupus Systemic lupus erythematosus, referred to as SLE or lupus, is sometimes called the "great imitator." Why? Because of its wide range of symptoms, people often confuse lupus with other health problems.
More informationContents. Systemic Lupus Erythematosus. Ellen M. Ginzler
Systemic Lupus Erythematosus Preface Ellen M. Ginzler xiii ChangingWorldwide Epidemiology of Systemic Lupus Erythematosus 1 Archana Vasudevan and Aneesa Niravel Krishnamurthy Developed countries have better
More informationWe are IntechOpen, the first native scientific publisher of Open Access books. International authors and editors. Our authors are among the TOP 1%
We are IntechOpen, the first native scientific publisher of Open Access books 3,350 108,000 1.7 M Open access books available International authors and editors Downloads Our authors are among the 151 Countries
More informationAutoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens:
Autoimmunity Reactivity to self antigens: Autoreactivity: Autoimmune Disease T cells B cells Leading to tissue damage or dysfunction Occurring in the absence of ongoing infection Epidemiology SLE Pathogenesis
More informationAutoimmunity. Autoimmune Disease
Autoimmunity Reactivity to self antigens: T cells B cells Autoimmune Disease Autoreactivity: Leading to tissue damage or dysfunction Occurring in the absence of ongoing infection 1 SLE Pathogenesis Immune
More informationNeuroimmunological and clinical studies in Neuropsychiatric Lupus Erythematosus (NPSLE)
From THE DEPARTMENT OF CLINICAL NEUROSCIENCE Karolinska Institutet, Stockholm, Sweden Neuroimmunological and clinical studies in Neuropsychiatric Lupus Erythematosus (NPSLE) Liisa Hopia Stockholm 2016
More informationThe Diagnosis of Lupus
The Diagnosis of Lupus LUPUSUK 2017 This information booklet has been produced by LUPUS UK 2017 LUPUS UK LUPUS UK is the registered national charity for people with systemic lupus erythematosus (SLE) and
More informationManifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria
Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria Farjah H AlGahtani Associate professor,md,mph Leukemia,Lymphoma in adolescent,thromboembolic
More informationSTUDY OF PSYCHIATRIC MANIFESTATIONS AND QUALITY OF LIFE AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
STUDY OF PSYCHIATRIC MANIFESTATIONS AND QUALITY OF LIFE AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. DISSERTATION SUBMITTED FOR Partial Fulfillment of the Rules and Regulations DOCTOR OF MEDICINE
More informationAsk the Expert: Photosensitivity in Cutaneous Lupus
Ask the Expert: Photosensitivity in Cutaneous Lupus Victoria P. Werth, MD Department of Dermatology & Medicine University of Pennsylvania ; Philadelphia VA Hospital Overview Definition Impact of photosensitivity
More informationArthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS
Arthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS Introduction: There is perhaps no rheumatic disease that evokes so much fear and confusion among both patients
More informationComparison of the Clinical Manifestations, Brain MRI and Prognosis between NeuroBehçet's Disease and Neuropsychiatric Lupus
The Korean Journal of Internal Medicine : 22:77-86, 27 Comparison of the Clinical Manifestations, Brain MRI and Prognosis between NeuroBehçet's Disease and Neuropsychiatric Lupus Byung-Sik Cho, M.D., Hyun-Sook
More informationDevelopment of SLE among Possible SLE Patients Seen in Consultation: Long-Term Follow-Up. Disclosures. Background. Evidence-Based Medicine.
Development of SLE among Patients Seen in Consultation: Long-Term Follow-Up Abstract # 1699 May Al Daabil, MD Bonnie L. Bermas, MD Alexander Fine Hsun Tsao Patricia Ho Joseph F. Merola, MD Peter H. Schur,
More informationLUPUS (SLE) MEDICAL SOURCE STATEMENT
LUPUS (SLE) MEDICAL SOURCE STATEMENT From: Re: (Name of Patient) (Social Security No.) Please answer the following questions concerning your patient s impairments. Attach relevant treatment notes, radiologist
More informationUndifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD
Undifferentiated Connective Tissue Disease and Overlap Syndromes Mark S. Box, MD Overlap Syndromes As many as 25% of patients with rheumatic diseases with systemic symptoms cannot be definitely diagnosed
More informationEvaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus
Clin Rheumatol (2016) 35:2449 2456 DOI 10.1007/s10067-016-3376-9 ORIGINAL ARTICLE Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus
More information.,Dr Ali Alkazzaz Babylon collage of medicine 2016
.,Dr Ali Alkazzaz Babylon collage of medicine 2016 Lupus history Lupus is the Latin word for wolf 1 st used medically in the 10 th century Described clinically in the 19 th century Butterfly rash in 1845
More informationAUTOIMMUNE DISORDERS IN THE ACUTE SETTING
AUTOIMMUNE DISORDERS IN THE ACUTE SETTING Diagnosis and Treatment Goals Aimee Borazanci, MD BNI Neuroimmunology Objectives Give an update on the causes for admission, clinical features, and outcomes of
More informationThe Neurology of HIV Infection. Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University
The Neurology of HIV Infection Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University HIV/AIDS Epidemiology World-wide pandemic, 40 million affected U.S.- Disproportionate
More informationPolicy. Section: Medicine Effective Date: January 15, 2015 Subsection: Pathology/Laboratory Original Policy Date: December 5, 2014 Subject:
Last Review Status/Date: December 2014 Page: 1 of 10 Summary Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease that can be difficult to diagnose because patients often present
More informationMANAGING THE PATIENT WITH POSITIVE ANA
MANAGING THE PATIENT WITH POSITIVE ANA Rafael F. Rivas-Chacon, M.D. Disclosures Grant/Research support for: Pfizer Study JIA A3921104 Tofacitinib not related to this presentation 1 Positive Antinuclear
More informationNeurological Complications of Rheumatic Disorders: Updates and Future Directions
Neurological Complications of Rheumatic Disorders: Updates and Future Directions Julius Birnbaum, MD/MHS Assistant Professor, Department of Neurology and Medicine Johns Hopkins Hospital No Relevant Financial
More informationSLE: Neuropsychiatric Lupus. Disclosures. Learning Objective 4/16/2018
SLE: Neuropsychiatric Lupus Richard Furie, MD Chief, Division of Rheumatology Northwell Health Professor of Medicine Zucker School of Medicine at Hofstra Northwell Disclosures Nothing to disclose in relationship
More informationSPECIFIC AIMS. V year (1st semester) Scientific Field NEUROLOGICAL SCIENCES TUTOR ECTS
V year (1st semester) Scientific Field NEUROLOGICAL SCIENCES TUTOR ECTS CENTONZE D. COORDINATOR MED/27 Neurosurgery Fraioli Mario Francesco 1 MED/26 Neurology Marfia Girolama Alessandra 2 MED/26 Neurology
More informationParadoxial Safety Signals from Biologics
Paradoxial Safety Signals from Biologics Christopher Ritchlin, MD, MPH Professor of Medicine Director, Translational Immunology Research Center University of Rochester Medical Center Rochester, NY Disclosures
More informationClinical and immunological characteristics of Polish patients with systemic lupus erythematosus
Original papers Clinical and immunological characteristics of Polish patients with systemic lupus erythematosus Martyna Tomczyk-Socha 1, B E, Hanna Sikorska-Szaflik 2, B E, Marek Frankowski 3, B D, Karolina
More informationSYSTEMIC LUPUS ERYTHEMATOSUS: CURRENT CONCEPTS AND CLINICAL PEARLS. Dr Sheila Vasoo Consultant Division of Rheumatology NUHS
SYSTEMIC LUPUS ERYTHEMATOSUS: CURRENT CONCEPTS AND CLINICAL PEARLS Dr Sheila Vasoo Consultant Division of Rheumatology NUHS Listen to the Patient Concepts Diagnosis Immunopathogenesis Clinical Pearls Disease
More informationCIBMTR Center Number: CIBMTR Recipient ID: RETIRED. Today s Date: Date of HSCT for which this form is being completed: &
Systemic Lupus Erythematosus Pre-HSCT Data Sequence Number: Date Received: Registry Use Only Today s Date: Date of HSCT for which this form is being completed: & HSCT type: o autologous o allogeneic, o
More informationNeurosarcoidosis. Walter Royal, III, MD Professor of Neurology and Anatomy and Neurobiology University of Maryland School of Medicine
Neurosarcoidosis Walter Royal, III, MD Professor of Neurology and Anatomy and Neurobiology University of Maryland School of Medicine Sarcoidosis A granulomatous disease of unknown etiology and no current
More informationAnshuman Srivastava, 1 Bijit Kumar Kundu, 2 and Diwakar Kumar Singh Introduction. 2. Case Presentation
Case Reports in Rheumatology Volume 2016, Article ID 5827860, 4 pages http://dx.doi.org/10.1155/2016/5827860 Case Report Concomitant Guillain Barre Syndrome and Transverse Myelitis as Initial Neuropsychiatric
More informationUPDATES ON PEDIATRIC SLE
UPDATES ON PEDIATRIC SLE BY ANGELA MIGOWA, PEDIATRIC RHEUMATOLOGIST/SENIOR INSTRUCTOR AKUHN MBCHB-UON, MMED-AKUHN,PEDIATRIC RHEUMATOLOGY- MCGILL UNIVERSITY HEALTH CENTRE ROSA PARKS OBJECTIVES RECOGNIZE
More informationA cross-sectional hospital based study of clinical and. patients from central rural India
original article A cross-sectional hospital based study of clinical and patients from central rural India Sachin Ratanlal Agrawal, Iadarilang Tiewsoh, Atulsingh Rajput, Ajitprasad Jain Access this article
More informationNeuropsychiatric manifestations are commonly. Neuropsychiatric Syndromes in Systemic Lupus Erythematosus: A Meta-Analysis SLE
SLE Neuropsychiatric Syndromes in Systemic Lupus Erythematosus: A Meta-Analysis Avraham Unterman, MD,*, Johannes E.S. Nolte, MD,*, Mona Boaz, PhD,, Maya Abady, MPT, Yehuda Shoenfeld, MD,*, and Gisele Zandman-Goddard,
More information. Autoimmune disease. Dr. Baha,Hamdi.AL-Amiedi Ph.D.Microbiology
. Autoimmune disease Dr. Baha,Hamdi.AL-Amiedi Ph.D.Microbiology, Paul Ehrich The term coined by the German immunologist paul Ehrich ( 1854-1915) To describe the bodys innate aversion to immunological
More informationthese mechanisms do not account for the majority of symptom complexes associated with NPSLE in particular, the insidious cognitive decline manifested
Differences in Regional Brain Activation Patterns Assessed by Functional Magnetic Resonance Imaging in Patients with Systemic Lupus Erythematosus Stratified by Disease Duration Meggan Mackay, 1 Mathew
More informationCommittee Approval Date: May 9, 2014 Next Review Date: May 2015
Medication Policy Manual Policy No: dru248 Topic: Benlysta, belimumab Date of Origin: May 13, 2011 Committee Approval Date: May 9, 2014 Next Review Date: May 2015 Effective Date: June 1, 2014 IMPORTANT
More informationINDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity
PLENARY S BREAKS NETWORKING EVENTS PARALLEL S INDUSTRY SUPPORTED S E-POSTERS SYMPOSIUM Monday, 14 May 2018 13:00-15:30 15:30 16:00 Coffee Break 16:00-17:30 Tuesday, 15 May 2018 08:00-08:30 08:30-10:30
More informationOriginal Article Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous
Int J Clin Exp Med 2015;8(9):16658-16663 www.ijcem.com /ISSN:1940-5901/IJCEM0011022 Original Article Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic
More informationINDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity
PLENARY S BREAKS NETWORKING EVENTS PARALLEL S INDUSTRY SUPPORTED S E-POSTERS SYMPOSIUM Monday, 14 May 2018 13:00-15:30 15:30 16:00 Coffee Break 16:00-17:30 Tuesday, 15 May 2018 08:00-08:30 08:30-10:30
More informationBREAKS NETWORKING EVENTS PARALLEL SESSIONS INDUSTRY SUPPORTED SESSIONS Academy of Autoimmunity SYMPOSIUM
PLENARY SESSIONS BREAKS NETWORKING EVENTS PARALLEL SESSIONS INDUSTRY SUPPORTED SESSIONS SYMPOSIUM Monday, 14 May 2018 13:00-15:30 15:30 16:00 COFFEE BREAK 16:00-17:30 Tuesday, 15 May 2018 08:00-08:30 08:30-10:30
More informationVasculiti secondarie del SNC
Alma Ticinensis Universitas Vasculiti secondarie del SNC Dr Lorenzo Cavagna Divisione di Reumatologia, Università e Fondazione IRCCS Policlinico S. Matteo, Pavia Chairman AENEAS collaborative group Responsabile
More informationSection: Medicine Effective Date: January 15, 2016 Subsection: Pathology/Laboratory Original Policy Date: December 5, 2014 Subject:
Last Review Status/Date: December 2015 Page: 1 of 11 Summary Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease that can be difficult to diagnose because patients often present
More informationStudy of Neuropsychiatric Manifestations and Immunological Markers in Systemic Lupus Erythematosus
Study of Neuropsychiatric Manifestations and Immunological Markers in Systemic Lupus Erythematosus Hafez N 1, Soltan L 1, Abo Ray AA 2, Hamdy M 1 Departments of Neuropsychiatry 1, Internal Medicine 2,
More informationPattern of Systemic Lupus Erythematosus in Tabuk, Saudi Arabia
Original article: Pattern of Systemic Lupus Erythematosus in Tabuk, Saudi Arabia Abdullah ALYOUSSUF 1, Bashar ALASSAR 2, Osama MOHAMMED*, 1, Hyder MIRGHANI 1, Palanisamy Amirthalingam 3 1Department of
More informationTreatment of Neuropsychiatric lupus. Dr HAJIALILO
Treatment of Neuropsychiatric lupus Dr HAJIALILO Treatment strategy Treatment Strategy Before NP-SLE Pathogenesis Signs symptoms Diagnosis Treatment Treatment strategy Treatment Strategy Before NP-SLE
More informationOriginal Article. Abstract
Original Article Diagnostic accuracy of antinuclear antibodies and anti-double stranded DNA antibodies in patients of systemic lupus erythematosus presenting with dermatological features Attiya Tareen*,
More informationImmune tolerance, autoimmune diseases
Immune tolerance, autoimmune diseases Immune tolerance Central: negative selection during thymic education deletion of autoreactive B-lymphocytes in bone marrow Positive selection in the thymus Negative
More informationBachelor of Chinese Medicine ( ) AUTOIMMUNE DISEASES
Bachelor of Chinese Medicine (2002 2003) BCM II Dr. EYT Chan February 6, 2003 9:30 am 1:00 pm Rm 134 UPB AUTOIMMUNE DISEASES 1. Introduction Diseases may be the consequence of an aberrant immune response,
More informationInfection-Associated Neurological Syndromes
Infection-Associated Neurological Syndromes Anand P, MD PhD Medical Director, BloodCenter of Wisconsin Assistant Professor, Medical College of Wisconsin ASFA Annual Meeting San Antonio, TX, May 8th, 2015
More informationPeter H. Schur Elena M. Massarotti. Editors. Lupus Erythematosus. Clinical Evaluation and Treatment
Lupus Erythematosus Peter H. Schur Elena M. Massarotti Editors Lupus Erythematosus Clinical Evaluation and Treatment Editors Peter H. Schur Division of Rheumatology, Immunology, Allergy Brigham and Women
More informationLupus as a risk factor for cardiovascular disease
Lupus as a risk factor for cardiovascular disease SØREN JACOBSEN Department Rheumatology, Rigshospitalet Søren Jacobsen Main sponsors: Gigtforeningen Novo Nordisk Fonden Rigshospitalet Disclaimer: Novo
More informationAntiphospholipid Syndrome Handbook
Antiphospholipid Syndrome Handbook Maria Laura Bertolaccini, Oier Ateka-Barrutia, and Munther A. Khamashta Antiphospholipid Syndrome Handbook Maria Laura Bertolaccini, MD, PhD Lupus Research Unit The Rayne
More informationEditing file. Color code: Important in red Extra in blue. Autoimmune Diseases
Editing file Color code: Important in red Extra in blue Autoimmune Diseases Objectives To know that the inflammatory processes in autoimmune diseases are mediated by hypersensitivity reactions (type II,
More informationPsychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease
Rheumatology 2008;47:1498 1502 Advance Access publication 25 July 2008 doi:10.1093/rheumatology/ken260 Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare
More informationSpring Semester OST 571 Neuromusculoskeletal Lecture-Lab Schedule Revised
Revised 1-07-16 Week 1: Monday, January 11, 2016 9:00-9:50 a.m. 001 - Principles of Neurobiology/Orientation Lovell Online 10:00-10:50 a.m. 002 - Cells, synapses & neurotransmitter systems Nazaroff Online
More informationMany Faces of Systemic Lupus Erythematosus. Prof. Md. Titu Miah Professor of Medicine Dhaka Medical College & Hospital
Many Faces of Systemic Lupus Erythematosus Prof. Md. Titu Miah Professor of Medicine Dhaka Medical College & Hospital The Very Appearance of SLE might be DECEIVING! NO TWO LUPUS PATIENTS HAVE EXACTLY THE
More informationPolicy. Background
Last Review Status/Date: December 2016 Page: 1 of 11 Summary Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease that can be difficult to diagnose because patients often present
More informationPS + MPs PS - MPs 37% 36% 64% 64%
Supplementary Figure 1. Amount and distribution of phosphatidylserine negative (PS - ) and phosphatidylserine positive (PS + ) MPs in 280 SLE patients and 280 controls. Circles are proportional to the
More informationEvaluation of Symptom-Oriented Selection of Computed Tomography or Magnetic Resonance Imaging for Neuropsychiatric Systemic Lupus Erythematosus
J Radiol Sci 2015; 40: 75-79 Evaluation of Symptom-Oriented Selection of Computed Tomography or Magnetic Resonance Imaging for Neuropsychiatric Systemic Lupus Erythematosus Hung-Wen Kao 1,2 Chao-Jan Wang
More informationDr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital
Dr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital Acknowledgements: KKCTH Dr. Ramkumar Consultant Dermatologist Dr. Ramprakash Consultant Ophthalmologist Dr. Prasad Manne
More informationSystemic Lupus Erythematosus
Systemic Lupus Erythematosus Translating Pathophysiology into New Therapies Traduciendo fisiopatologia en nuevos tratamentos Asociacion Costarricense Medicina Interna August 7, 2015 Arthur Weinstein, MD,
More informationSpring Semester OST 571 Neuromusculoskeletal Lecture-Lab Schedule
Week 1: Monday, January 5, 2015 9:00-9:50 a.m. 001 - Principles of Neurobiology Lovell Online 10:00-10:50 a.m. 002 - Cells, synapses & neurotransmitters Nazaroff Online 11:00-11:50 a.m. 003 - Development
More information10/25/2018. Autoimmunity and how to treat it. Disclosure. Why do we get autoimmunity? James Verbsky MD/PhD Pediatric Rheumatology/Immunology
Autoimmunity and how to treat it James Verbsky MD/PhD Pediatric Rheumatology/Immunology Disclosure None I will mention drug names and some brand names but I have no financial interest or any other ties
More informationMedical Immunology Practice Questions-2016 Autoimmunity + Case Studies
Medical Immunology Practice Questions-2016 Autoimmunity + Case Studies Directions: Each of the numbered items or incomplete statements in this section is followed by answers or by completions of the statement.
More informationCentral nervous system
Central nervous system By Dr. Mohsen Dashti Clinical Medicine & Pathology 316 7 th Lecture Lecture outline Review of structure & function. Symptoms, signs & tests. Specific diseases. Review of structure
More informationCSTAR CASE STUDIES: BLOCK F Type 3 Hypersensitivity Reaction
CSTAR CASE STUDIES: BLOCK F Type 3 Hypersensitivity Reaction Setting: ER Mr. Smith I ve just felt so weak for so long, and I ve lost so much weight, and now I m having trouble breathing it s affecting
More informationSIADH as Presenting Feature in a Male with Coexisting Sarcoidosis and Systemic Lupus
SIADH as Presenting Feature in a Male with Coexisting Sarcoidosis and Systemic Lupus Santhiya Govindaraj 1, Stalin Viswanathan 2, Bhavith Remalayam 1, Balamurugesan Kandan 2, Shanthi Kumar 3 1 Department
More informationOrganic Mental Disorders. Organic Mental Disorders. Axes. Damrongsak Bulyalert Department of Internal Medicine
Organic Mental Disorders Damrongsak Bulyalert Department of Internal Medicine www.metadon.net 1 Organic Mental Disorders In DSM (Diagnostic and Statistical Manual of Mental Disorders), OMD includes Delirium,
More informationConflict of Interest. Systemic Lupus Erythematosus and the Antiphospholipid Syndrome Bonnie L. Bermas, MD Brigham and Women s Hospital.
Systemic Lupus Erythematosus and the Antiphospholipid Syndrome Bonnie L. Bermas, MD Brigham and Women s Hospital Conflict of Interest Disclosures: None Overview Diagnostic Classification Criteria of SLE
More informationA neuroimaging follow-up study of a patient with juvenile central nervous system systemic lupus erythematosus
A neuroimaging follow-up study of a patient with juvenile central nervous system systemic lupus erythematosus 11 137 MRI studies on NPSLE A neuroimaging follow-up study of a patient with juvenile central
More informationLiving with Lupus. LFA - Georgia Gary E Myerson MD Arthritis and Rheumatology of GA
Living with Lupus LFA - Georgia Gary E Myerson MD Arthritis and Rheumatology of GA LUPUS A REALITY CHECK LUPUS A REALITY CHECK LUPUS A REALITY CHECK LUPUS A REALITY CHECK SLE 1.5 million Americans: some
More informationTo live with lupus, we need to know about lupus.
To live with lupus, we need to know about lupus. Zineb Aouhab, MD Assistant Professor of Medicine Loyola University Medical Center Division of Rheumatology 1 Where did the word lupus come from? The word
More informationLupus The Clinical Perspective
Lupus The Clinical Perspective Anca D. Askanase, M.D., M.P.H. Associate Professor of Medicine Director Lupus Center Columbia University Medical Center New York-Presbyterian Hospital Systemic Lupus Erythematosus
More informationMetabolic and microstructural alterations in the SLE brain correlate with cognitive impairment
Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment Meggan Mackay,, Betty Diamond, David Eidelberg JCI Insight. 2019;4(1):e124002.. Research Article Neuroscience
More informationLife Science Journal 2016;13(11) Predictors of MRI Brain Changes in Systemic Lupus Erythematosus Patients
Predictors of MRI Brain Changes in Systemic Lupus Erythematosus Patients Yasser El Miedany 1, Sami M Bahlas 2, Yasser M Bawazir 3, Ibtisam M Jali 4 1 Honorary senior clinical lecturer, King's college London,
More informationA RARE NEUROLOGICAL PRESENTATION OF SLE. Dr Yoganand M N Dr Prithvi P Nayak
A RARE NEUROLOGICAL PRESENTATION OF SLE Dr Jayachandra Dr Yoganand M N Dr Prithvi P Nayak Presenter: Dr Shambhavi K R CHIEF COMPLAINTS A 30 year old lady hailing from Nepal presented to OPD with complaints
More informationNeurologic Complications of Systemic Lupus Erythematosus, Sjögren Syndrome, and Rheumatoid Arthritis
425 Neurologic Complications of Systemic Lupus Erythematosus, Sjögren Syndrome, and Rheumatoid Arthritis Shamik Bhattacharyya, MD, MS 1,2,3 Simon M. Helfgott, MD 4,5 1 Department of Neurology, Massachusetts
More informationRheumatology 101 A Pediatrician s Guide
Rheumatology 101 A Pediatrician s Guide Pediatric Staff and Alumni Day 2016 Dawn M. Wahezi, Yonit Sterba, Tamar Rubinstein Disclosures None Pick a Group Group 1 A child with a limp Group 2 ANA To test
More informationSystemic Lupus Erythematosus Defining Lupus
Autoimmune Resource and Research Centre Information Sheet Systemic Lupus Erythematosus Defining Lupus Lupus is a disorder of the immune system known as an autoimmune disease. In autoimmune diseases, the
More information